Arkolith/Insider Trading/VRCA/Form 4

Goldenberg Gary

Chief Medical OfficerVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Jul 23, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$131K
Net Open-Market Flow
-$131K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 23, 2024Sell(S)86$6.98$600108K
Jul 22, 2024Sell(S)18K$7.06$130K108K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-019972) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML